“Future Role of Non-Insulin Antihyperglycemic Agents in the Management of Type 1 Diabetes Mellitus” (2023) Canadian Diabetes & Endocrinology Today, 1(2), pp. 9–14. doi:10.58931/cdet.2023.1211.